Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prometheus: Everolimus in maintenance liver transplant
NCT03596970Phase 3Withdrawn
- Sponsor
- Novartis
- Start
- Sep 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of everolimus in Liver transplant rejection, sponsored by Novartis. Planned start Sep 2015; status: withdrawn.
02
Drugs
everolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT03596970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03596970.